Next Article in Journal
4-Chloro-6-ethoxy-2-(methylthio)pyrimidine
Previous Article in Journal
N-[2-(Cyclohexylamino)-2-oxoethyl]-N-(4-octyloxy)phenyl-prop-2-enamide
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

(2E,2′E)-3-(4-{[4-(4-Hydroxy-3-methoxyphenyl)but-2-en-1-yl]oxy}phenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one

1
Division of Organic Chemistry, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Jl. Ganesa 10, Bandung 40132, Indonesia
2
Department of Pharmacy, Faculty of Medicine and Public Health, Universitas Jenderal Soedirman, Purwokerto 53122, Indonesia
*
Author to whom correspondence should be addressed.
Molbank 2017, 2017(1), M922; https://doi.org/10.3390/M922
Submission received: 2 December 2016 / Revised: 19 December 2016 / Accepted: 20 December 2016 / Published: 27 December 2016
(This article belongs to the Section Organic Synthesis)

Abstract

:
A hybrid of eugenol and a chalcone has been synthesized in good yield via cross olefin metathesis. The title compound (3) was characterized by spectroscopic data including NMR, infrared, and ESI-MS.

1. Introduction

The assembly of natural product hybrids has been an interesting strategy to gain new leads in drug discovery [1]. A convenient method to synthesize hybrid molecules is olefin cross metathesis. The hybrid molecule is formed from two precursors in which each molecule contains a terminal olefin in the presence of olefin metathesis catalysts [2]. The olefin metathesis reaction takes place with a wide tolerance to many organic functional groups. This is ideal to make hybrid molecules from natural products without any additional protective group. Eugenol is a major component of the essential oil from cloves, and plays an important role in the antibacterial activity of clove oil against Salmonella typhi [3]. The allyl group of eugenol is an important functional group in producing hybrid molecules of eugenol and other compounds. In our program to produce a library of compounds for antibacterial screening, we synthesized and modified some natural product compounds [4]. In this paper, we report the synthesis of a hybrid molecule between eugenol (2) and a chalcone (1) in the presence of Grubbs II catalyst (Scheme 1). By using Grubbs II catalyst, we found that the reaction took place at the allyl groups and furnished an E olefin as the major product (see Figure S2 in the supplementary for more details) [5].

2. Experimental Section

All chemicals and solvents for reactions were purchased from commercial suppliers and were used without purification. All solvents for chromatography were distilled before use. The melting point was determined with a Fisher-Johns Melting Point Apparatus and is uncorrected. Fourier transform infrared (FTIR) spectra were recorded with an FTIR prestige 21 Shimadzu instrument (Shimadzu Corp., Kyoto, Japan). 1H- and 13C-NMR (1D and 2D) spectra were recorded on an Agilent DD2 system operating at 500 MHz (1H) and 125 MHz (13C) (Agilent Technologies Inc., Santa Clara, CA, USA). High-resolution mass spectra was obtained with an ESI-TOF (ElectroSpray Ionisation—Time Of Flight) Waters LCT Premier XE mass spectrometer (Waters Corp., Milford, MA, USA).

Preparation of Compound 3

A mixture of (E)-1-(2,4-dimethoxy)-3-(4′-allyloxy)prop-2-en-1-one (1) (45 mg, 0.145 mmol, 1 eq), eugenol (2) (477 mg, 2.9 mmol, 20 eq) and Grubbs catalyst 2nd Generation (6.2 mg, 7.25 × 10−3 μmol, 5.3 mol%) in CH2Cl2 (7.5 mL) was stirred for 2 h at 40 °C under N2 atmosphere. The reaction was monitored by thin layer chromatography (TLC) analysis. After completion of the reaction, the mixture was concentrated in vacuo. Purification of the product was done by radial chromatography with n-hexane:acetone (20:2) to give a mixture of compound 3 and an inseparable isomer (2′Z) of 3 (9:1) as an orange solid (63 mg, 94%), m.p.: 114–115 °C. FTIR (KBr): 3448 (stretch OH, H bond), 2920 (stretch CH3 sp3), 1631 (stretch C=O), 1566 and 1446 (stretch C=C aromatic), 1220 and 1012 (stretch C-O-Ar) cm−1. 1H-NMR (500 MHz, CDCl3) δ ppm: 13.55 (s, 1H, H2′); 7.86 (d, J = 15.5 Hz, 1H, Hβ); 7.82 (d, J = 8.5 Hz, 1H, H6′); 7.59 (d, J = 9.0 Hz, 2H, H2/6); 7.45 (d, J = 15.5 Hz, 1H, Hα); 6.94 (d, J = 8.5 Hz, 2H, H3/5); 6.86 (d, J = 8.0 Hz, 1H, H9′′); 6.68 (d, J = 10 Hz, 2H, H5′/10′′); 6.48 (dd, J = 11 and 2.5 Hz, 2H, H3′/6′′); 6.01 (dt, J = 15.0 and 6.0 Hz, 1H, H2′′); 5.75 (dt, J = 15.0 and 6.0 Hz, 1H, H3′′); 4.56 (d, J = 6.0 Hz, 2H, H1′′); 3.85 (s, 6H, 4′-OCH3/7′′-OCH3); 3.37 (d, J = 6.5 Hz, 2H, H4′′). 13C-NMR (125 MHz, CDCl3) δ ppm: 192.0 (C=O); 166.7 (C2′); 166.2 (C4′); 161.0 (C4); 146.6 (C7′′); 144.4 (C8′′); 144.2 (Cβ); 134.8 (C2′′); 131.4 (C5′′); 130.4 (C2/6); 130.2 (C6′); 127.7 (C1); 125.5 (C3′′); 121.3 (C10′′); 118.0 (Cα); 115.3 (C3/5); 114.5 (C1′); 114.3 (C9′′); 111.2 (C5′); 107.7 (C6′′); 101.2 (C3′); 68.7 (C1′′); 56.0 (4′-OCH3); 55.7 (7′′-OCH3); 38.5 (C4′′). HR-ESI-TOF MS for C27H26O6 ([M + H]+) calculated: m/z 447.1808, found: m/z 447.1801.

Supplementary Materials

The 1H, 13C, 2D 1H-13C HSQC and 2D 1H-13C HMBC NMR spectra are available online at: www.mdpi.com/1422-8599/2017/1/M922.
Supplementary File 1Supplementary File 2Supplementary File 3Supplementary File 4

Acknowledgments

This research was partially supported by Directorate General of Higher Education, Ministry of Education and Culture, Indonesia and the Indonesian Oil Palm Estate Fund.

Author Contributions

Didin Mujahidin and Yana M. Syah designed the experiment. Muhamad S. Fareza executed the experiment. All authors interpreted data and prepare the manuscript in the same contribution.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tietze, L.F.; Bell, H.P.; Chandrasekhar, S. Natural product hybrids as new leads for drug discovery. Angew. Chem. Int. Ed. 2003, 42, 3996–4028. [Google Scholar] [CrossRef] [PubMed]
  2. Dragutan, I.; Dragutan, V.; Demonceau, A. Targeted drugs by olefin metathesis: Piperidine-based iminosugars. RSC Adv. 2012, 2, 719–736. [Google Scholar] [CrossRef]
  3. Devi, K.P.; Nisha, S.A.; Sakthivel, R.; Pandian, S.K. Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonela typhi by disrupting the cellular membrane. J. Ethnopharmacol. 2010, 130, 107–115. [Google Scholar] [CrossRef] [PubMed]
  4. Fareza, M.S.; Syah, Y.M.; Mujahidin, D.; Juliawaty, L.D.; Kurniasih, I. Antibacterial Flavanones and Dihydrochalcones from Macaranga trichocarpa. Z. Naturforsch. 2014, 69c, 375–380. [Google Scholar] [CrossRef]
  5. Chatterjee, A.K.; Choi, T.-L.; Sanders, D.P.; Grubbs, R.H. A General Model for Selectivity in Olefin Cross Metathesis. J. Am. Chem. Soc. 2003, 125, 11360–11370. [Google Scholar] [CrossRef] [PubMed]
Scheme 1. Synthesis of chalcone and eugenol hybrid by cross olefin metathesis reaction.
Scheme 1. Synthesis of chalcone and eugenol hybrid by cross olefin metathesis reaction.
Molbank 2017 m922 sch001

Share and Cite

MDPI and ACS Style

Fareza, M.S.; Mujahidin, D.; Syah, Y.M. (2E,2′E)-3-(4-{[4-(4-Hydroxy-3-methoxyphenyl)but-2-en-1-yl]oxy}phenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one. Molbank 2017, 2017, M922. https://doi.org/10.3390/M922

AMA Style

Fareza MS, Mujahidin D, Syah YM. (2E,2′E)-3-(4-{[4-(4-Hydroxy-3-methoxyphenyl)but-2-en-1-yl]oxy}phenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one. Molbank. 2017; 2017(1):M922. https://doi.org/10.3390/M922

Chicago/Turabian Style

Fareza, Muhamad S., Didin Mujahidin, and Yana M. Syah. 2017. "(2E,2′E)-3-(4-{[4-(4-Hydroxy-3-methoxyphenyl)but-2-en-1-yl]oxy}phenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one" Molbank 2017, no. 1: M922. https://doi.org/10.3390/M922

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop